Publication: 3073

Publication: 3073

Long-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial

DOI

URL

Google Scholar

Citation:: Annals of Oncology vol 30 (Supplement_3) iii65–iii71

Meeting Instance:: ESMO Breast 2019
Year:: 2019
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3181

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: GSK/Novartis
Grants:

Corr. Author:
Authors:: D. Eiger N. F. Ponde D. Agbor-Tarh Alvaro Moreno-Aspitia Martine Piccart Richard Rodeheffer Michael Ewers Thomas Suter E. de Azambuja

Networks:: LAPS-MN026

Study: NCCTG-N063D
Multiple Studies, or Legacy Studies in Alliance Study:: ALTTO
Phases:: 3, 3

Keywords:: HER2 positive breast cancer; cardio-toxicity; lapatinib; trastuzumab